作者
M Colaianna, Paolo Tucci, M Zotti, MARIA GRAZIA Morgese, Stefania Schiavone, Stefano Govoni, Vincenzo Cuomo, Luigia Trabace
发表日期
2010/4
期刊
British journal of pharmacology
卷号
159
期号
8
页码范围
1704-1715
出版商
Blackwell Publishing Ltd
简介
Background and purpose:  Depression is common in early phases of Alzheimer's disease (AD) and may represent prodromal symptoms of dementia. Recent reports suggest that early memory deficits and neuropsychiatric symptoms are caused by soluble rather than aggregated βamyloid (Aβ). Thus, we investigated the effects of soluble Aβ1‐42 on working memory and depressive/anxiety‐related behaviour in rats and on 5‐hydroxytryptaminergic neurotransmission and neurotrophin content in various brain regions.
Experimental approach:  Behavioural reactivity to novel object recognition, open field, elevated plus maze and forced swimming test were assessed 7 days after i.c.v. injection of Aβ1‐42 or its vehicle. BDNF (brain‐derived neurotrophic factor) and NGF (nerve growth factor) mRNA and protein levels and 5‐hydroxytriptamine (5‐HT) content were measured in the prefrontal cortex (PFC), striatum (STR …
引用总数
20102011201220132014201520162017201820192020202120222023202413368711101914311584